Malaria during pregnancy and transplacental transfer of Kaposi sarcoma-associated herpesvirus (KSHV) antibodies: a cohort study of Kenyan mother and child pairs

Background: Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in sub-Saharan African kids can vary as much as 50% by age 2 years however components affecting early age of KSHV an infection should not effectively understood. Malaria throughout being pregnant has been related to hindered transplacental switch of antibodies to a number of pathogens however whether or not it impacts transplacental switch of KSHV antibodies is unknown. We aimed to find out if in utero malaria publicity decreased the switch of KSHV antibodies throughout the placenta.
Strategies: A cohort examine in Kisumu, Kenya enrolled pregnant ladies at their first antenatal clinic (ANC) go to and adopted them via supply. We included 70 KSHV-positive, HIV-negative moms and their kids. KSHV antibody ranges have been measured by ELISA (K8.1, ORF73) and multiplex assay. Transplacental switch of antibodies was measured by the wire to maternal blood ratio (CMR) of KSHV antibodies. Malaria throughout being pregnant was outlined as detection of Plasmodium falciparum (Pf) DNA at any ANC go to or supply. Amongst ladies with malaria throughout being pregnant, we examined time of final malaria an infection previous to supply and malaria incidence fee.
Outcomes: KSHV seroprevalence (constructive for K8.1 or ORF73 by ELISA) amongst pregnant ladies was 88%. Neither malaria throughout being pregnant, malaria an infection timing, nor MIR have been related to maternal supply KSHV antibody blood ranges. Maternal supply and twine blood KSHV antibody ranges have been extremely correlated however these correlations didn’t differ by malaria throughout being pregnant. KSHV transplacental antibody switch was not related to malaria throughout being pregnant, malaria an infection timing, nor MIR.
Conclusions: Malaria throughout being pregnant doesn’t seem to have an effect on switch of KSHV antibodies throughout the placenta.

Dynamic modifications in anti-SARS-CoV-2 antibodies throughout SARS-CoV-2 an infection and restoration from COVID-19

Deciphering the dynamic modifications in antibodies in opposition to SARS-CoV-2 is important for understanding the immune response in COVID-19 sufferers. Right here we analyze the laboratory findings of 1,850 sufferers to explain the dynamic modifications of the whole antibody, spike protein (S)-, receptor-binding area (RBD)-, and nucleoprotein (N)-specific immunoglobulin M (IgM) and G (IgG) ranges throughout SARS-CoV-2 an infection and restoration. The era of S-, RBD-, and N-specific IgG happens one week later in sufferers with extreme/essential COVID-19 in comparison with sufferers with gentle/average illness, whereas S- and RBD-specific IgG ranges are 1.5-fold greater in extreme/essential sufferers throughout hospitalization. The RBD-specific IgG ranges are 4-fold greater in older sufferers than in youthful sufferers throughout hospitalization.
As well as, the S- and RBD-specific IgG ranges are 2-fold greater within the recovered sufferers who’re SARS-CoV-2 RNA damaging than those that are RNA constructive. Decrease S-, RBD-, and N-specific IgG ranges are related to a decrease lymphocyte proportion, greater neutrophil proportion, and an extended period of viral shedding. Sufferers with low antibody ranges on discharge would possibly thereby have a excessive probability of being examined constructive for SARS-CoV-2 RNA after restoration. Our examine gives necessary data for COVID-19 analysis, remedy, and vaccine growth.
Throughout the coronavirus illness 2019 (COVID-19) pandemic, many international locations skilled an infection in healthcare staff (HCW) resulting from overburdened healthcare techniques. Nevertheless, whether or not contaminated HCW purchase protecting immunity in opposition to SARS-CoV-2 is unclear. Right here, we characterised SARS-CoV-2-specific antibody responses in Norwegian HCW in a potential cohort examine.
Malaria during pregnancy and transplacental transfer of Kaposi sarcoma-associated herpesvirus (KSHV) antibodies: a cohort study of Kenyan mother and child pairs
Malaria during pregnancy and transplacental transfer of Kaposi sarcoma-associated herpesvirus (KSHV) antibodies: a cohort study of Kenyan mother and child pairs

A randomized, multicentre, open-label section II proof-of-concept trial investigating the medical efficacy and security of the addition of convalescent plasma to the usual of care in sufferers hospitalized with COVID-19: the Donated Antibodies Working in opposition to nCoV (DAWn-Plasma) trial

Background: The COVID-19 pandemic has imposed an infinite burden on well being care techniques all over the world. Up to now, the administration of convalescent plasma of sufferers having recovered from SARS and extreme influenza to sufferers actively having the illness confirmed promising results on mortality and appeared secure. Whether or not or not this additionally holds true for the novel SARS-CoV-2 virus is at present unknown.
Strategies: DAWn-Plasma is a multicentre nation-wide, randomized, open-label, section II proof-of-concept medical trial, evaluating the medical efficacy and security of the addition of convalescent plasma to the usual of care in sufferers hospitalized with COVID-19 in Belgium. Sufferers hospitalized with a confirmed analysis of COVID-19 are eligible when they’re symptomatic (i.e. medical or radiological indicators) and have been recognized with COVID-19 within the 72 h earlier than examine inclusion via a PCR (nasal/nasopharyngeal swab or bronchoalveolar lavage) or a chest-CT scan displaying options suitable with COVID-19 within the absence of an alternate analysis. Sufferers are randomized in a 2:1 ratio to both customary of care and convalescent plasma (energetic remedy group) or customary of care solely. The energetic remedy group receives 2 items of 200 to 250 mL of convalescent plasma inside 12 h after randomization, with a second administration of two items 24 to 36 h after ending the primary administration. The trial goals to incorporate 483 sufferers and can recruit from 25 centres throughout Belgium. The first endpoint is the proportion of sufferers that require mechanical air flow or have died at day 15. The primary secondary endpoints are medical standing on day 15 and day 30 after randomization, as outlined by the WHO Development 10-point ordinal scale, and security of the administration of convalescent plasma.

MIP-3

EF017888 96 Tests
EUR 826.8

MIP-3

EF012726 96 Tests
EUR 826.8

MIP-3

EF013760 96 Tests
EUR 826.8

MIP-3

EF013761 96 Tests
EUR 826.8

MIP-3

EF010865 96 Tests
EUR 826.8

MIP-3

PAab09791 100 ug
EUR 463.2

anti- MIP antibody

FNab05193 100µg
EUR 658.5
Description: Antibody raised against MIP

Anti-MIP antibody

PAab05193 100 ug
EUR 463.2

Anti-MIP antibody

STJ24556 100 µl
EUR 332.4
Description: Major intrinsic protein is a member of the water-transporting aquaporins as well as the original member of the MIP family of channel proteins. The function of the fiber cell membrane protein encoded by this gene is undetermined, yet this protein is speculated to play a role in intracellular communication. The MIP protein is expressed in the ocular lens and is required for correct lens function. This gene has been mapped among aquaporins AQP2, AQP5, and AQP6, in a potential gene cluster at 12q13.

MIP-3, CCL23, human

RC315-34 5ug
EUR 125.26

Anti-MIP-3 Alpha/CCL20 Antibody

A00748-2 100ug/vial
EUR 352.8

Rabbit Anti Human Mip-3 Alpha Polyclonal Antibody

CPBT-65216RH 0.1 mg
EUR 1057.2

Rabbit Anti Human Mip-3 Beta Polyclonal Antibody

CPBT-65218RH 0.1 mg
EUR 1057.2

Anti-MIP-1b Antibody

A16621 100ul
EUR 476.4
Description: Rabbit Polyclonal Antibody for MIP-1b Antibody (CCL4L1) detection. Tested with WB in Human.

Anti-MIP-5 Antibody

A05563 100ul
EUR 476.4
Description: Rabbit Polyclonal Antibody for MIP-5 Antibody (CCL15) detection.tested for IHC in Human.

anti- MIP-3α antibody

FNab09791 100µg
EUR 658.5
Description: Antibody raised against MIP-3α

Anti-MIP- alpha antibody

STJ94130 200 µl
EUR 236.4
Description: Rabbit polyclonal to MIP-1alpha.

Anti-MIP- beta antibody

STJ94131 200 µl
EUR 236.4
Description: Rabbit polyclonal to MIP-3beta.

Anti-MIP-T3 antibody

STJ94133 200 µl
EUR 236.4
Description: Rabbit polyclonal to MIP-T3.

Anti-MIP- beta antibody

STJ96572 200 µl
EUR 236.4
Description: Rabbit polyclonal to MIP-1beta.

Anti-MIP-1b antibody

STJ97347 200 µl
EUR 236.4
Description: Rabbit polyclonal to MIP-1b.

Anti-MIP- alpha antibody

STJ98775 200 µl
EUR 236.4
Description: Rabbit polyclonal to MIP-3alpha.

Anti-MIP-5 antibody

STJ98780 200 µl
EUR 236.4
Description: Rabbit polyclonal to MIP-5.

MIP-3/CCL23, human recombinant

7175-10
EUR 248.4

MIP-3/CCL23, human recombinant

7175-50
EUR 810

MIP-3-alpha/CCL20, Human

HY-P7262 10ug
EUR 321.6

MIP-3 alpha, CCL20, human

RC315-31 5ug
EUR 125.26

Anti-MIP-3 alpha Antibody Biotin Conjugated

B00748-1 100ug
EUR 518.4
Description: Rabbit Polyclonal MIP-3 alpha Antibody Biotin Conjugated. Validated in WB and tested in Human.

Anti-VEGF Receptor 3/FLT4 Antibody

A01276-3 100ug/vial
EUR 400.8

Polyclonal Goat anti-GST α-form

GST-ANTI-1 50 uL
EUR 336

Polyclonal Goat anti-GST μ-form

GST-ANTI-2 50 uL
EUR 336

Anti-Human IBA1 Antibody

M01394-3 100ul
EUR 476.4
Description: Chicken Polyclonal Human IBA1 Antibody. Validated in IF, IHC, WB and tested in Human.

Anti-Human Ki67 Antibody

M00254-3 100ul
EUR 476.4
Description: Rabbit Polyclonal Human Ki67 Antibody. Validated in IHC, WB and tested in Human, Mouse, Rat.

Anti-14-3-3 alpha + beta Rabbit Monoclonal Antibody

M02431-3 100ug/vial
EUR 476.4
Description: Rabbit Monoclonal 14-3-3 alpha + beta Antibody. Validated in Flow Cytometry, IP, IF, IHC, ICC, WB and tested in Human, Mouse, Rat.

Rabbit Anti Human Mip-3 Beta Polyclonal Antibody,Biotin

CPBT-65217RH 50 µg
EUR 1057.2

Anti-Galectin 3/LGALS3 Antibody (monoclonal, 12B12)

M00621-3 100ug/vial
EUR 400.8

Anti-active Caspase-3 Rabbit Monoclonal Antibody

M00334-3 100ug/vial
EUR 476.4
Description: Anti-active Caspase-3 Rabbit Monoclonal Antibody tested for IF, IHC, ICC, WB in Human

rHu MIP-3-beta

AK8232-0005 5µg Ask for price

rHu MIP-3-beta

AK8232-0020 20µg Ask for price

rHu MIP-3-beta

AK8232-0100 100µg Ask for price

rHu MIP-3-beta

AK8232-1000 1mg Ask for price

rHu MIP-3-alpha

AK8271-0005 5µg Ask for price

rHu MIP-3-alpha

AK8271-0020 20µg Ask for price

rHu MIP-3-alpha

AK8271-0100 100µg Ask for price

rHu MIP-3-alpha

AK8271-1000 1mg Ask for price

MIP-3? Polyclonal Antibody

ES7130-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against MIP-3? from Human. This antibody is tested and validated for IHC, WB, ELISA

MIP-3? Polyclonal Antibody

ES7130-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against MIP-3? from Human. This antibody is tested and validated for IHC, WB, ELISA

MIP-3? Polyclonal Antibody

ES8712-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against MIP-3? from Human/Mouse. This antibody is tested and validated for IHC, WB, ELISA

MIP-3? Polyclonal Antibody

ES8712-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against MIP-3? from Human/Mouse. This antibody is tested and validated for IHC, WB, ELISA

MIP-3 Recombinant Protein

40-379-0005mg 0.005 mg
EUR 311.1
Description: MIP-3 is a CC chemokine that signals through the CCR1 receptor. MIP-3 chemoattracts monocytes, resting T-lymphocytes and neutrophils, but does not chemoattract activated lymphocytes. Additionally, MIP-3 has been shown to inhibit colony formation of bone marrow myeloid immature progenitors. Recombinant human MIP-3 is an 11.3 kDa protein containing 99 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

MIP-3 Recombinant Protein

40-379-002mg 0.02 mg
EUR 437.1
Description: MIP-3 is a CC chemokine that signals through the CCR1 receptor. MIP-3 chemoattracts monocytes, resting T-lymphocytes and neutrophils, but does not chemoattract activated lymphocytes. Additionally, MIP-3 has been shown to inhibit colony formation of bone marrow myeloid immature progenitors. Recombinant human MIP-3 is an 11.3 kDa protein containing 99 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

MIP-3-beta Antibody

abx235194-100ug 100 ug
EUR 577.2

Anti-MIP-1 alpha Antibody

A00405 100ug
EUR 518.4
Description: Rabbit Polyclonal MIP-1 alpha Antibody. Validated in WB and tested in Mouse.

Anti-Aquaporin 0/MIP Antibody

PA2110 100ug/vial
EUR 352.8

Anti-Aquaporin 0/MIP Antibody

PB9811 100ug/vial
EUR 352.8

Anti-CXCL2 / MIP-2 antibody

STJ71916 100 µg
EUR 430.8

Anti-Glyceraldehyde 3-Phosphate Dehydrogenase [GAPDH] Monoclonal Antibody

M00227-3 100ul
EUR 476.4
Description: Mouse Monoclonal Glyceraldehyde 3-Phosphate Dehydrogenase [GAPDH] Antibody. Validated in IHC, WB and tested in Equine.

MIP-3/CCL23 (CHO-expressed), Human

HY-P7259 10ug
EUR 321.6

Recombinant Human MIP-3 (CCL23) Protein

PROTP55773-1 20ug
EUR 380.4
Description: MIP-3 is a CC chemokine that signals through the CCR1 receptor. MIP-3 chemoattracts monocytes, resting T-lymphocytes and neutrophils, but does not chemoattract activated lymphocytes. Additionally, MIP-3 has been shown to inhibit colony formation of bone marrow myeloid immature progenitors. Recombinant human MIP-3 is an 11.3 kDa protein containing 99 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

Mip/ Rat Mip ELISA Kit

ELI-23038r 96 Tests
EUR 1063.2

Anti-CCL19/Mip 3 Beta Rabbit Monoclonal Antibody

M01605 100ug/vial
EUR 476.4
Description: Rabbit Monoclonal CCL19/Mip 3 Beta Antibody. Validated in WB and tested in Human.

Anti-MRP1 (human) Monoclonal Antibody (QCRL-1)

M00872-3 1ml
EUR 810
Description: Mouse Monoclonal MRP1 (human) Antibody (QCRL-1). Validated in IP, IF and tested in Human.

Recombinant Human MMP-3 Protein

PROTP08254-3 10ug
EUR 380.4
Description: Matrix metalloproteinases (MMPs) are a family of endoproteases that require zinc and calcium for expressing catalytic activity. These enzymes play a central role in the maintenance and remodeling of the extracellular matrix. Elevated expression of their activity, caused either by up-regulation of their expression or down-regulation of their cognate inhibitors, has been implicated in various degenerative disorders, including arthritis, cardiovascular disease, skeletal growth-plate disorders, and cancer metastasis. MMP-3 degrades fibronectin, laminin, collagens III, IV, and X, and cartilage proteoglycans. Recombinant human MMP-3 is a 42.8 kDa protein containing the entire catalytic N-terminal domain and the C-terminal domain (378 amino acids).

Anti-Human IgM Rabbit Monoclonal Antibody, Clone#RM121

M07469-3 100ug
EUR 450
Description: Anti-Human IgM Rabbit Monoclonal Antibody, Clone#RM121 tested in ICC, IHC, FC, ELISA, reactive to Human

IL-3 Interleukin-3 Human Recombinant Protein, His Tag

PROTP08700-3 Regular: 50ug
EUR 380.4
Description: Interleukin-3 Human Recombinant produced in E.Coli is single, a non-glycosylated, Polypeptide chain containing 154 amino acids fragment (20-152) and having a total molecular mass of 17.3kDa and fused with a 20 aa N-terminal His tag. ;The IL3 His is purified by proprietary chromatographic techniques.

MIP Antibody

1-CSB-PA167583
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against MIP. Recognizes MIP from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:50-1:200

mip Antibody

1-CSB-PA401660HA01LLJ
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against mip. Recognizes mip from Legionella pneumophila. This antibody is Unconjugated. Tested in the following application: ELISA

MIP Antibody

1-CSB-PA152107
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against MIP. Recognizes MIP from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:500-1:5000, IHC:1:50-1:200

MIP Antibody

1-CSB-PA283369
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against MIP. Recognizes MIP from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:50-1:200

MIP Antibody

1-CSB-PA000910
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against MIP. Recognizes MIP from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/5000

MIP Antibody

1-CSB-PA013834GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against MIP. Recognizes MIP from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB

MIP Antibody

1-CSB-PA013834LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against MIP. Recognizes MIP from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:200-1:500, IF:1:50-1:200

MIP Antibody

1-CSB-PA884370
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against MIP. Recognizes MIP from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:20-1:100

MIP antibody

70R-18519 50 ul
EUR 522
Description: Rabbit polyclonal MIP antibody

MIP Antibody

36125-100ul 100ul
EUR 302.4

MIP antibody

10R-10490 100 ug
EUR 522
Description: Mouse monoclonal MIP antibody

MIP antibody

10R-10491 100 ug
EUR 522
Description: Mouse monoclonal MIP antibody

MIP siRNA

20-abx924187
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

MIP siRNA

20-abx924188
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

MIP-1

EF016651 96 Tests
EUR 826.8

MIP-1

EF016834 96 Tests
EUR 826.8

MIP-1

EF017045 96 Tests
EUR 826.8

MIP-1

EF017887 96 Tests
EUR 826.8

MIP-1

EF012725 96 Tests
EUR 826.8

MIP-1

EF013758 96 Tests
EUR 826.8

MIP-1

EF013759 96 Tests
EUR 826.8

MIP-1

EF000186 96 Tests
EUR 826.8

Human MIP shRNA Plasmid

20-abx952903
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

MIP-1alpha, human recombinant

4244-100
EUR 1038

MIP-1alpha, human recombinant

4244-1000
EUR 5572.8

MIP-1alpha, human recombinant

4244-20
EUR 379.2

MIP-1beta, human recombinant

4247-10
EUR 379.2

MIP-1beta, human recombinant

4247-1000
EUR 6558

MIP-3alpha, human recombinant

4491-1000
EUR 4653.6

MIP-3alpha, human recombinant

4491-20
EUR 320.4

MIP-3beta, human recombinant

4494-1000
EUR 6558

MIP-3beta, human recombinant

4494-20
EUR 379.2

MIP-4/CCL18, Human

HY-P7265 50ug
EUR 639.6

MIP-5/CCL15, Human

HY-P7266 50ug
EUR 555.6

MIP ELISA KIT|Human

EF000798 96 Tests
EUR 826.8

MIP-5, CCL15, human

RC315-26 5ug
EUR 125.26

MIP Recombinant Protein (Human)

RP041341 100 ug Ask for price

FSH (Human Follicle-stimulating hormone) ELISA test

3 96T/Box Ask for price
Description: ELISA based test for quantitative detection of FSH (Human Follicle-stimulating hormone)

MIP-3 alpha Recombinant Protein

40-353-0005mg 0.005 mg
EUR 311.1
Description: MIP-3 alpha is a CC chemokine that is expressed in the liver, lymph nodes, appendix, PBL and lung and signals through the CCR6 receptor. MIP-3 alpha is chemotactic towards lymphocytes and dendritic cells. Additionally, it promotes the adhesion of memory CD4+ T cells and inhibits colony formation of bone marrow myeloid immature progenitors. Recombinant murine MIP-3 alpha is a 7.9 kDa protein containing 70 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

MIP-3 alpha Recombinant Protein

40-353-002mg 0.02 mg
EUR 437.1
Description: MIP-3 alpha is a CC chemokine that is expressed in the liver, lymph nodes, appendix, PBL and lung and signals through the CCR6 receptor. MIP-3 alpha is chemotactic towards lymphocytes and dendritic cells. Additionally, it promotes the adhesion of memory CD4+ T cells and inhibits colony formation of bone marrow myeloid immature progenitors. Recombinant murine MIP-3 alpha is a 7.9 kDa protein containing 70 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

MIP-3 beta Recombinant Protein

40-354-0005mg 0.005 mg
EUR 311.1
Description: MIP-3 beta is a CC chemokine that is expressed in the thymus, lymph nodes and in activated bone marrow stromal cells and signals through the CCR7 receptor. MIP-3 beta is a chemoattractant for T and B lymphocytes and myeloid progenitor cells. Human MIP-3 beta is active on murine cells. Recombinant murine MIP-3 beta is a 9.2 kDa protein containing 83 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

MIP-3 beta Recombinant Protein

40-354-002mg 0.02 mg
EUR 437.1
Description: MIP-3 beta is a CC chemokine that is expressed in the thymus, lymph nodes and in activated bone marrow stromal cells and signals through the CCR7 receptor. MIP-3 beta is a chemoattractant for T and B lymphocytes and myeloid progenitor cells. Human MIP-3 beta is active on murine cells. Recombinant murine MIP-3 beta is a 9.2 kDa protein containing 83 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

MIP-3 alpha Recombinant Protein

40-380-0005mg 0.005 mg
EUR 311.1
Description: MIP-3 alpha is a CC chemokine that is expressed in the liver, lymph nodes, appendix, PBL and lung and can signal through the CCR6 receptor. MIP-3 alpha is chemotactic towards lymphocytes and dendritic cells. Additionally, it promotes the adhesion of memory CD4+ T cells and inhibits colony formation of bone marrow myeloid immature progenitors. Recombinant human MIP-3 alpha is an 8.0 kDa protein containing 70 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

MIP-3 alpha Recombinant Protein

40-380-002mg 0.02 mg
EUR 437.1
Description: MIP-3 alpha is a CC chemokine that is expressed in the liver, lymph nodes, appendix, PBL and lung and can signal through the CCR6 receptor. MIP-3 alpha is chemotactic towards lymphocytes and dendritic cells. Additionally, it promotes the adhesion of memory CD4+ T cells and inhibits colony formation of bone marrow myeloid immature progenitors. Recombinant human MIP-3 alpha is an 8.0 kDa protein containing 70 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

MIP-3 beta Recombinant Protein

40-381-0005mg 0.005 mg
EUR 311.1
Description: MIP-3 beta is a CC chemokine that is expressed in the thymus, lymph nodes and in activated bone marrow stromal cells and signals through the CCR7 receptor. MIP-3 beta is a chemoattractant for T and B lymphocytes and myeloid progenitor cells. Human MIP-3 beta is active on murine cells. Recombinant human MIP-3 beta is an 8.8 kDa protein containing 77 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

MIP-3 beta Recombinant Protein

40-381-002mg 0.02 mg
EUR 437.1
Description: MIP-3 beta is a CC chemokine that is expressed in the thymus, lymph nodes and in activated bone marrow stromal cells and signals through the CCR7 receptor. MIP-3 beta is a chemoattractant for T and B lymphocytes and myeloid progenitor cells. Human MIP-3 beta is active on murine cells. Recombinant human MIP-3 beta is an 8.8 kDa protein containing 77 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

MIP-3-alpha/CCL20, Mouse

HY-P7263 10ug
EUR 280.8

MIP-3-beta/CCL19, Mouse

HY-P7264 50ug
EUR 639.6

Ccl20 Antibody / Mip-3 alpha

R32858 100 ug
EUR 419

Ccl19 Antibody / Mip-3 beta

R32903 100 ug
EUR 419

Human CCL19/MIP-3 beta ELISA Kit

LF-EK50840 1×96T
EUR 777.6

MIP-3-alpha/CCL20 (CHO-expressed), Human

HY-P7260 10ug
EUR 321.6

MIP sgRNA CRISPR Lentivector (Human) (Target 3)

K1304004 1.0 ug DNA
EUR 184.8

Recombinant Human MIP-3 Beta (CCL19) Protein

PROTQ99731-1 20ug
EUR 380.4
Description: MIP-3β is a CC chemokine that is expressed in the thymus, lymph nodes and in activated bone marrow stromal cells and signals through the CCR7 receptor. MIP-3β is a chemoattractant for T and B lymphocytes and myeloid progenitor cells. Human MIP-3β is active on murine cells. Recombinant human MIP-3β is an 8.8 kDa protein containing 77 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

Recombinant Human MIP-3 Alpha (CCL20) Protein

PROTP78556-2 20ug
EUR 380.4
Description: MIP-3α is a CC chemokine that is expressed in the liver, lymph nodes, appendix, PBL and lung and can signal through the CCR6 receptor. MIP-3α is chemotactic towards lymphocytes and dendritic cells. Additionally, it promotes the adhesion of memory CD4+ T cells and inhibits colony formation of bone marrow myeloid immature progenitors. Recombinant human MIP-3α is an 8.0 kDa protein containing 70 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

Human MIP-3 alpha/CCL20 ELISA Kit

RK00207 96 Tests
EUR 625.2

Goat Anti Human Mip-1 Alpha Polyclonal Antibody

CPBT-65207GH 0.1 mg
EUR 1057.2

Rabbit Anti Human Mip-1 Beta Polyclonal Antibody

CPBT-65212RH 0.1 mg
EUR 1057.2

Anti-Human CD45 Monoclonal Antibody Unconjugated Conjugated, Flow Validated

FC00555-3 Various Sizes
EUR 121.2
Description: Mouse Monoclonal Human CD45 Antibody Unconjugated Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-Human IgG4 Fc Rabbit Monoclonal Antibody, Clone#RM217

M11385-3 100ug
EUR 492
Description: Anti-Human IgG4 Fc Rabbit Monoclonal Antibody, Clone#RM217 tested in FC, ELISA , reactive to Human

Anti-RAB3GAP2 Antibody

A07244-3 100ug/vial
EUR 400.8

Anti-FOXI1 Antibody

A07512-3 100ug/vial
EUR 400.8

Anti-RBMS3 Antibody

A12416-3 100ug/vial
EUR 400.8

Anti-IL17B Antibody

A10846-3 100ug/vial
EUR 352.8

Anti-PYROXD1 Antibody

A17214-3 100ug/vial
EUR 400.8

Anti-TFF3 Antibody

A01738-3 100ug/vial
EUR 400.8

Anti-IFNAR2 Antibody

A02056-3 100ug/vial
EUR 400.8
Dialogue: This trial will both present assist or discourage the usage of convalescent plasma as an early intervention for the remedy of hospitalized sufferers with COVID-19 an infection.

Leave a Reply

Your email address will not be published.